Reuters reports that Regeneron Pharmaceuticals’s “Eylea significantly improved vision in patients with diabetic macular edema (DME) compared to laser surgery in two late-stage clinical trials.” Eylea has been approved for use against wet age-related macular edema, but these results are...

A study in Nature Biotechnology reports that “irreversible blindness caused by loss of photoreceptors may be amenable to cell therapy.” Using embryonic stem cells (ESCs), scientists were able to grow new retina cells in a lab, and then placed them into blind mice. Researchers found that these...

BBC News reports that the Japanese government approved the “first trial of stem cells produced from a patient’s own body.” The researchers behind the new study plan to utilize the newly cultivated stem cells to treat age-related macular degeneration. Whereas embryonic stem cells have...